{"id":"W1966067024","doi":"10.1089/apc.2007.0136","title":"Potential for New Antiretrovirals to Address Unmet Needs in the Management of HIV-1 Infection","year":2008,"lang":"en","type":"review","venue":"AIDS Patient Care and STDs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Gilead Sciences; Merck","keywords":"Raltegravir; Maraviroc; Medicine; Etravirine; Intensive care medicine; Rilpivirine; CCR5 receptor antagonist; Antiretroviral therapy; Enfuvirtide; Integrase inhibitor; Dosing; Human immunodeficiency virus (HIV); Dolutegravir; Cart; Viral load; Pharmacology; Immunology; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007871243,0.0003222451,0.0009912974,0.0005201029,0.00006823229,0.00001587909,0.00008808951,0.0001400628,0.00001181683],"category_scores_gemma":[0.000008742302,0.0002039572,0.0003362732,0.0005982323,0.00002482061,0.00003970103,0.00006929597,0.0001200534,0.00001061446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000117076,"about_ca_system_score_gemma":0.0001174421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000043131,"about_ca_topic_score_gemma":0.000006195191,"domain_scores_codex":[0.9985538,0.0000661162,0.0005407733,0.0002833125,0.0003204754,0.0002355143],"domain_scores_gemma":[0.9993526,0.00004911819,0.0001591793,0.0002804399,0.00006599264,0.00009267464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004044109,0.0001051039,0.0006472208,0.006594724,0.0003939855,0.00004637424,0.002228308,0.000001038346,8.624599e-8,0.0001150612,0.003925094,0.9859025],"study_design_scores_gemma":[0.001464496,0.01217119,0.0001296308,0.008668956,0.001931943,0.00004384436,0.0009291369,8.471053e-7,0.000007089041,0.000007720359,0.97437,0.0002751591],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01375068,0.9799041,0.0001723775,0.00002106838,0.0002554115,0.004127054,0.000107667,0.00002028313,0.001641325],"genre_scores_gemma":[0.01269235,0.9832229,0.001350816,0.00004597055,0.00008891083,0.0003268593,0.0008070935,0.00003040383,0.00143468],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9856274,"threshold_uncertainty_score":0.8317133,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02715115993716108,"score_gpt":0.3103111054010281,"score_spread":0.283159945463867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}